Delivery Order SPE2DB22D2005-SPE2DB25FJPC4
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,708.50 by the Defense Logistics Agency on August 12, 2025, for Fluticasone Propionate 50 micrograms spray in 16-gram units. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 13, 2025, and represents a non-set-aside competitive award. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on August 6, 2025, for Fluticasone Propionate 50 MCG Spray in a 16-gram formulation, valued at $1,045.02. The contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 7, 2025. Performance will take place at the company's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,365.73 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) on July 22, 2025, with completion scheduled for July 23, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical supply transaction executed under the company's existing contract vehicle with DLA. The award was placed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Fluticasone Propionate HFA 44 micrograms in 10.6-gram inhalers, with a ceiling value of $4,633.71. This competitive award, utilizing firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 billion through December 2026. The order is set to be completed by...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,366.24 by the Defense Logistics Agency (DLA) for the supply of Fluticasone Propionate 50 micrograms nasal spray in 16-gram units. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and will be fulfilled from the company's Corporate Office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation applied. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,500.54 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 micrograms spray (16 grams) on June 26, 2025, with completion scheduled for June 27, 2025. This competitively awarded, firm fixed-price contract was issued without set-aside provisions. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for Fluticasone Prop 50 MCG Spray 16GM, with a contract value of $2,105.64. The award, issued on September 15, 2025, represents a firm fixed price delivery order with an ultimate completion date of September 16, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Fluticasone Propionate 50 mcg spray in 16-gram units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $7,572.98 and is scheduled for completion by September 12, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,158.11 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 mcg spray (16 gm) on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a continuation of AmerisourceBergen's extensive supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 23, 2025, for the supply of Fluticasone Propionate 50 MCG Spray in 16GM units, with a ceiling value of $1,730.88. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJPC4Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on June 26, 2025, for the supply of Fluticasone Propionate 50 mcg spray in 16 gram units, with a ceiling value of $1,682.80 and a firm fixed price structure. This delivery order, which represents a child contract under a larger indefinite delivery vehicle, is scheduled for completion by June 27, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation applied. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support military healthcare systems and other federal government customers. The DLA's pharmaceutical procurement strategy emphasizes flexible contracting vehicles that enable efficient delivery of critical medical supplies across multiple therapeutic domains to support defense health operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 6/26/25 |